Use of 18FDG-PET/CT to predict outcome in patient with locally advanced pancreatic cancer

被引：0
|
作者：
Locantore, L. [1 ]
Mapelli, P. [1 ]
Incerti, E. [1 ]
Alongi, P. [2 ]
Gangemi, V. [3 ]
Passoni, P. [4 ]
Slim, N. [4 ]
Di Muzio, N. [4 ]
Gianolli, L. [1 ]
Picchio, M. [1 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Dept Nucl Med, Milan, Italy
[2] Univ Milano Bicocca, Milan, Italy
[3] Univ Messina, Nucl Med Unit, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy
[4] IRCCS San Raffaele Sci Inst, Radiotherapy Dept, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP300
引用
收藏
页码：S125 / S126
页数：2
相关论文
共 50 条
  • [31] Helical Tomotherapy with Simultaneous Integrated Boost 18FDG-Pet Based in Radical Locally Advanced Head and Neck Cancer
    Dell'oca, I.
    Fiorino, C.
    Caimi, M.
    Chiara, A.
    Rognone, A.
    Pasetti, M.
    Broggi, S.
    Landoni, C.
    Calandrino, R.
    Di Muzio, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S406 - S406
  • [32] Advanced artificial intelligence framework for T classification of TNM lung cancer in 18FDG-PET/CT imaging
    Trabelsi, Mariem
    Romdhane, Hamida
    Ben Salem, Lotfi
    Ben-Sellem, Dorra
    BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 2024, 10 (06):
  • [33] Can post neoadjuvant chemotherapy 18F-FDG PET/CT predict residual cancer burden in locally advanced breast cancer?
    Topuz, O. Vural
    Akkurt, T. S.
    Erdem, G. U.
    Kaya, E. M.
    Kaya, M.
    Akkas, B. E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2024, 48 (03): : 141 - 149
  • [34] [18F]FDG-PET/CT results predict outcome in breast cancer
    Sollini, M.
    Zangheri, B.
    Calabrese, L.
    Di Paolo, M.
    Versari, A.
    Gasparini, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S623 - S623
  • [35] 18FDG-PET in the evaluation of patologic response after treatment and clinical outcome in oesophageal cancer's patient
    Gasparini, M. D.
    Benti, R.
    Colombo, F. R.
    Rognoni, G. Cabrini M.
    Canzi, C.
    Gerundini, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S161 - S162
  • [36] Imaging in SCCHN: Can SUVmax of pretreatment FDG PET/CT in locally advanced SCCHN predict treatment outcome?
    Bunea, A.
    Kerti, H.
    Wiedenmann, N.
    Mix, M.
    Grosu, A. L.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S622 - S623
  • [37] Clinical impact of 18FDG-PET and PET/CT in the evaluation of pathologic response after treatment in oesophageal cancer's patient
    Gasparini, M. D.
    Florimonte, L.
    Valisi, E.
    Leo, R.
    Benti, R.
    Gerundini, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S178 - S178
  • [38] FDG PET/CT predicts patient outcome and guides dose escalation with tomotherapy for locally advanced head and neck cancer patients
    Kirienko, M.
    Dell'Oca, I.
    Incerti, E.
    Chiara, A.
    Fiorino, C.
    Mapelli, P.
    Fodor, A.
    Pasetti, M.
    Vanoli, E.
    Calandrino, R.
    Di Muzio, N.
    Gianolli, L.
    Picchio, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S339 - S339
  • [39] Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
    Erkan Topkan
    Cem Parlak
    Ayşe Kotek
    Ali Fuat Yapar
    Berrin Pehlivan
    BMC Gastroenterology, 11
  • [40] 18FDG-PET/CT Imaging of External Ear Sarcoidosis
    Guedj, Eric
    Chiche, Laurent
    Basely, Mathieu
    Cammilleri, Serge
    Durand, Jean-Marc
    Mundler, Olivier
    OTOLOGY & NEUROTOLOGY, 2010, 31 (04) : 699 - 700
12345